Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinton Medicare Rx Benefit To Add Medical Error Reduction Component

Executive Summary

President Clinton's updated Medicare drug benefit proposal for 2000 will highlight the importance of reducing clinical errors, Office of Management & Budget Associate Director-Health and Personnel Daniel Mendelson told the National Congress on the Future of Pharmaceuticals in Medical Care Dec. 9 in Washington, D.C.

You may also be interested in...



Drug Name Mix-Ups To Be Addressed In Sen. Kennedy's Patient Safety Bill

FDA would be required to adopt a program to minimize drug name confusion under patient safety legislation proposed by Sen. Kennedy (D-Mass.).

Breaux/Frist Medicare Board Is One Sore Spot In Rx Firms' Favored Bill

A federal Medicare Board will likely be one of the most sensitive issues for the brand name pharmaceutical industry in deciding how enthusiastically to support Medicare reform legislation introduced Nov. 9 by Sens. Breaux (D-La.), Frist (R-Tenn.), Kerrey (D-Neb.) and Hagel (R-Neb.).

Clinton Medicare PBM Proposal Could Include Multiple Providers Per Region

The White House is willing to consider allowing more than one pharmacy benefit manager per region to provide a Medicare drug benefit under its PBM-based Medicare proposal.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel